同济大学学报（医学版）2023，Vol.44Issue(6)：777-784,8.DOI:10.12289/j.issn.1008-0392.23330
《原发性骨质疏松症诊疗指南(2022版)》解读
Interpretation of the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis(2022)
袁玲丹 1宋利格2
作者信息
- 1. 同济大学附属同济医院内分泌代谢科,上海 200065||同济大学医学院骨质疏松和代谢性骨病研究所,上海 200065||同济大学医学院,上海 200092
- 2. 同济大学附属同济医院内分泌代谢科,上海 200065||同济大学医学院骨质疏松和代谢性骨病研究所,上海 200065
- 折叠
摘要
Abstract
Guidelines for the diagnosis and treatment of primary osteoporosis(2022)developed by the Chinese Society of Osteoporosis and Bone Mineral Research have been recently released.On the basis of the 2017 version,the current version of guidelines have incorporated the latest developments in the epidemiology,pathogenesis,disease diagnosis and treatment options for primary osteoporosis from both domestic and international sources over the past five years to provide guidance for clinical practice.This article interprets the main updates of the new guidelines.关键词
骨质疏松/骨质疏松性骨折/诊疗指南/骨折风险/药物疗法Key words
osteoporosis/osteoporotic fractures/guidelines for diagnosis and treatment/fracture risk/drug therapy分类
医药卫生引用本文复制引用
袁玲丹,宋利格..《原发性骨质疏松症诊疗指南(2022版)》解读[J].同济大学学报（医学版）,2023,44(6):777-784,8.
